Malignant News and Research

RSS

African-American men less likely to use more targeted biopsy option for prostate cancer

Researchers at the University of Cincinnati have found in a retrospective study that African-American men are less likely to use a more targeted biopsy option for prostate cancer, despite an increased incidence in this group of patients.

17 Mar 2020

MicroRNA dysregulation has critical impacts on development, inflammation and cancer development

Oncotarget Volume 11, Issue 10 reported that dysregulation of noncoding micro RNA molecules has been associated with immune cell activation in the context of Helicobacter pylori-induced gastric inflammation as well as carcinogenesis, but also with downregulation of mismatch repair genes, and may interfere with immune checkpoint proteins that lead to the overexpression of antigens on gastric tumor cells.

13 Mar 2020

Prize-winning research offers a promising approach to improve regenerative medicine

Joana Neves is the 2019 grand prize winner of the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy, for work that offers a promising approach to improve the outcome of regenerative stem cell-based therapies aimed at delaying age-related degenerative diseases.

12 Mar 2020

Understanding how cancer cells interact and collaborate to metastasize

Cancer cells are known to migrate and collaborate to form networks that function as conduits providing access to nutrients and blood vessels.

12 Mar 2020

Exploiting careless cancer cells to develop new drugs

Could the ability of cancer cells to quickly alter their genome be used as a weapon against malignant tumors? Researchers at Uppsala University have succeeded in developing a substance that has demonstrated promising results in experiments on both animal models and human cancer cells.

11 Mar 2020

Inherited ventricular arrhythmia fairly common among Finnish Leonbergers

A new study in Finland has revealed that inherited malignant ventricular arrhythmia is fairly common among Finnish Leonbergers under three years of age. At its worst, such arrhythmia can result in the dog's sudden death.

10 Mar 2020

$3 million grant helps Dartmouth engineers to develop multi-modal breast imaging platform

Most people who undergo breast biopsies do not have cancer, according to Cancer.org, so a group of researchers are trying to minimize the number of unnecessary biopsies using an innovative technique that combines two commonly-used methods.

7 Mar 2020

Aggressive features in papillary thyroid microcarcinoma raises the risk for distant metastasis

Although papillary thyroid carcinoma is the most common form of thyroid malignancy, it is considered to be an indolent disease that progresses slowly and has an excellent prognosis.

6 Mar 2020

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer, has awarded additional funding of up to $16 million to four teams of top researchers as part of its "New Therapies Challenge Grants," the American Association for Cancer Research, Scientific Partner of SU2C, announced today.

5 Mar 2020

Researchers detect a novel cause of acquired lipodystrophy

Nonalcoholic fatty liver disease (NAFLD) is mostly diagnosed in overweight and obese people. However, severe forms of NAFLD can also be detected in rare genetic diseases such as lipodystrophy or in patients with HIV, putting them at a high risk for developing liver failure, diabetes and cardiovascular diseases.

3 Mar 2020

New drug could help significantly improve success rate of cancer immunotherapy

A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug - originally developed to tackle the scarring of organ tissue - could help to significantly improve the success rate of cancer immunotherapy treatment.

2 Mar 2020

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

An interdisciplinary team from the Institute of Radiopharmaceutical Cancer Research headed by Prof. Peter Brust has won HZDR's (Helmholtz-Zentrum Dresden-Rossendorf) third Innovation Contest.

27 Feb 2020

NTHU research team develops new treatment for cancer

A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a new treatment for cancer, in which blood vessels within malignant tumors are normalized by injecting a specially developed nanodelivery system for nitric oxide (NanoNO), which also facilitates the delivery of cancer drugs and immunocytes into the tumor.

27 Feb 2020

Brain imaging may help predict when liquid biopsy will benefit individual glioblastoma patients

Tracking brain cancer with a blood test instead of a surgical biopsy may greatly improve quality of life for glioblastoma (GBM) patients and provide critical information for their care, but it is not feasible in all cases.

27 Feb 2020

Scientists developing a combined vaccine to fight most malignant brain tumor

Scientists are developing a combined vaccine to fight the most deadly form of brain cancer.

25 Feb 2020

Guiding nanoparticles directly to the tumor cells

Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells.

24 Feb 2020

Simple blood test could be used by GPs to aid in earlier brain tumor diagnosis

A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.

24 Feb 2020

New methods to decipher how natural substances affect the body’s hormone balance

A team of researchers from Vienna has developed methods of deciphering precisely how plants and medicinal substances affect the body’s own hormone balance. Initial analyses show that in high doses some natural substances promote the growth of breast cancer cells.

24 Feb 2020

New evidence-based clinical guidelines for surgical treatment of thyroid disease

The first set of comprehensive, evidence-based clinical guidelines for surgical treatment of thyroid disease - developed by an expert panel assembled by the American Association of Endocrine Surgeons - was published today by Annals of Surgery.

23 Feb 2020

Researchers reveal new vulnerability in MYC-driven lymphomas

Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells.

20 Feb 2020

Malignant News and Research

African-American men less likely to use more targeted biopsy option for prostate cancer

MicroRNA dysregulation has critical impacts on development, inflammation and cancer development

Prize-winning research offers a promising approach to improve regenerative medicine

Understanding how cancer cells interact and collaborate to metastasize

Exploiting careless cancer cells to develop new drugs

Inherited ventricular arrhythmia fairly common among Finnish Leonbergers

$3 million grant helps Dartmouth engineers to develop multi-modal breast imaging platform

Aggressive features in papillary thyroid microcarcinoma raises the risk for distant metastasis

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

Researchers detect a novel cause of acquired lipodystrophy

New drug could help significantly improve success rate of cancer immunotherapy

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

NTHU research team develops new treatment for cancer

Brain imaging may help predict when liquid biopsy will benefit individual glioblastoma patients

Scientists developing a combined vaccine to fight most malignant brain tumor

Guiding nanoparticles directly to the tumor cells

Simple blood test could be used by GPs to aid in earlier brain tumor diagnosis

New methods to decipher how natural substances affect the body’s hormone balance

New evidence-based clinical guidelines for surgical treatment of thyroid disease

Researchers reveal new vulnerability in MYC-driven lymphomas

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News